Morbihan Disease: Successful treatment with Slow-Releasing Doxycycline monohydrate

Abstract

Morbihan Disease (MD), designated so after the place of origin of the first ever reported patient by R. Degos in 1957, is a rare disorder of unknown etiology, characterized by a persistent, erythematous, non-pitting, solid edema of the middle and upper third of the face with a non-specific histology¹. The hallmark of MD is its refractoriness to treatment, oral isotretinoin and tetracyclines being the most successful therapeutic approaches.

This article is protected by copyright. All rights reserved.

http://ift.tt/2fPuK8t